← FDA Drug Approvals (Drugs@FDA)
OXYMETAZOLINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2022-10-28
Drug application
- FDA Application #
ANDA211812- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXYMETAZOLINE
- Generic name
- Oxymetazoline
- Active ingredients
- OXYMETAZOLINE
- Dosage form
- CREAM
- Route
- TOPICAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- TEVA PHARMS USA INC
- First approval
- 2022-10-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown